Jeet Mahal
2022
In 2022, Jeet Mahal earned a total compensation of $1.1M as Chief Operating and Financial Officer and Corporate Secretary at Jasper Therapeutics, a 140% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $161,192 |
|---|---|
| Option Awards | $358,433 |
| Salary | $418,265 |
| Stock Awards | $169,630 |
| Total | $1,107,520 |
Mahal received $418.3K in salary, accounting for 38% of the total pay in 2022.
Mahal also received $161.2K in non-equity incentive plan, $358.4K in option awards and $169.6K in stock awards.
Rankings
In 2022, Jeet Mahal's compensation ranked 2,791st out of 5,538 executives tracked by ExecPay. In other words, Mahal earned more than 49.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,791 out of 5,538 | 50th |
Division Manufacturing | 1,550 out of 3,000 | 48th |
Major group Chemicals And Allied Products | 713 out of 1,350 | 47th |
Industry group Drugs | 665 out of 1,253 | 47th |
Industry Biological Products, Except Diagnostic Substances | 165 out of 287 | 43rd |
Source: SEC filing on April 21, 2023.
Mahal's colleagues
We found three more compensation records of executives who worked with Jeet Mahal at Jasper Therapeutics in 2022.